Selective Early Medical Treatment of the Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot Randomized Controlled Trial (the SMART PDA Trial)
Selective Early Medical Treatment of the Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot Randomized Controlled Trial (the SMART PDA Trial)
极低胎龄婴儿动脉导管未闭的选择性早期医学治疗：一项随机对照试验（SMART PDA 试验）
批准号：
441822
负责人：
Mitra Souvik
金额：
$7.61万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-02-01 至 2024-02-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background
Among preterm infants, those born at a gestational age less than 26 weeks are considered the most vulnerable with a high risk of short- and long-term health problems that include chronic lung disease, brain bleeds, gut injury, kidney failure an
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Relative effectiveness and safety of pharmacotherapeutic agents for treatment of patent ductus arteriosus (PDA) in preterm infants: A National Comparative Effectiveness Research (CER) Project
-
批准号：410247
-
项目类别：Operating Grants
-
资助金额：$22.85万
-
财政年份：2019
-
负责人：Mitra Souvik
-
依托单位：
海外基金
